bf/NASDAQ:RGEN_icon.jpeg

NASDAQ:RGEN

Repligen

  • Stock

USD

Last Close

144.98

06/11 21:01

Market Cap

6.76B

Beta: 1.08

Volume Today

458.59K

Avg: 597.16K

PE Ratio

94.12

PFCF: 118.81

    Description

    Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography pro...Show More

    Earnings

    Earnings per Share (Estimate*)

    0.20.40.60.812018-12-312020-07-302022-02-172023-10-312024-11-12

    Revenue (Estimate*)

    50M100M150M200M2018-12-312020-07-302022-02-172023-10-312024-11-12

    *Estimate based on analyst consensus